About ICBCCS SSE Star Biology & Medicine ETF

588860 invests in stocks. The fund's major sectors are Health Technology, with 89.13% stocks, and Process Industries, with 3.64% of the basket. The assets are mostly located in the Asia region.

588860 top holdings are Shanghai United Imaging Healthcare Co., Ltd. Class A and BeOne Medicines Ltd. Class A, occupying 9.69% and 6.11% of the portfolio correspondingly.

588860 assets under management is ‪244.97 M‬ CNY. It's risen 25.57% over the last month.

588860 fund flows account for ‪−413.51 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

588860 shares are issued by ICBC UBS Asset Management Co. Ltd. under the brand ICBC. The ETF was launched on Aug 8, 2024, and its management style is Passive.

588860 follows the SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

588860 invests in stocks.

588860 price has risen by 0.33% over the last month, and its yearly performance shows a 28.70% increase. See more dynamics on 588860 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −1.93% over the last month, have fallen by −1.93% over the last month, showed a −3.87% decrease in three-month performance and has increased by 38.10% in a year.